Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment
Authors
Keywords
-
Journal
CANCER AND METASTASIS REVIEWS
Volume 31, Issue 3-4, Pages 763-778
Publisher
Springer Nature
Online
2012-06-18
DOI
10.1007/s10555-012-9388-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Galectin 1 Proangiogenic and Promigratory Effects in the Hs683 Oligodendroglioma Model Are Partly Mediated through the Control of BEX2 Expression
- (2015) Marie Le Mercier et al. NEOPLASIA
- Evidence of Heavy Methylation in the Galectin 3 Promoter in Early Stages of Prostate Adenocarcinoma: Development and Validation of a Methylated Marker for Early Diagnosis of Prostate Cancer
- (2014) Hafiz Ahmed et al. Translational Oncology
- Vascular Normalization by Loss of Siah2 Results in Increased Chemotherapeutic Efficacy
- (2012) C. S. F. Wong et al. CANCER RESEARCH
- Inhibiting galectin-1 reduces murine lung metastasis with increased CD4+ and CD8+ T cells and reduced cancer cell adherence
- (2012) Koichi Ito et al. CLINICAL & EXPERIMENTAL METASTASIS
- Human Prostate Cancer in a Clinically Relevant Xenograft Mouse Model: Identification of β(1,6)-Branched Oligosaccharides as a Marker of Tumor Progression
- (2012) Tobias Lange et al. CLINICAL CANCER RESEARCH
- High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion
- (2012) Ha-Jeong Kim et al. EUROPEAN JOURNAL OF CANCER
- Galectin-3 increases the motility of mouse melanoma cells by regulating matrix metalloproteinase-1 expression
- (2012) Yuan-Guo Wang et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- A novel radioresistant mechanism of galectin-1 mediated by H-Ras-dependent pathways in cervical cancer cells
- (2012) E-Y Huang et al. Cell Death & Disease
- Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress
- (2011) Koichi Ito et al. ANGIOGENESIS
- Neuropilin-1 mediates PDGF stimulation of vascular smooth muscle cell migration and signalling via p130Cas
- (2011) Caroline Pellet-Many et al. BIOCHEMICAL JOURNAL
- Tumor Galectin-1 Mediates Tumor Growth and Metastasis through Regulation of T-Cell Apoptosis
- (2011) A. Banh et al. CANCER RESEARCH
- Taloside Inhibitors of Galectin-1 and Galectin-3
- (2011) Patrick M. Collins et al. Chemical Biology & Drug Design
- Transient silencing of galectin-3 expression promotes both in vitro and in vivo drug-induced apoptosis of human pancreatic carcinoma cells
- (2011) Tsutomu Kobayashi et al. CLINICAL & EXPERIMENTAL METASTASIS
- Molecular Pathways: Hypoxia Response in Immune Cells Fighting or Promoting Cancer
- (2011) Asis Palazón et al. CLINICAL CANCER RESEARCH
- Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of β-catenin
- (2011) Tsutomu Kobayashi et al. INTERNATIONAL JOURNAL OF CANCER
- Peracetylated 4-Fluoro-glucosamine Reduces the Content and Repertoire ofN- andO-Glycans without Direct Incorporation
- (2011) Steven R. Barthel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Anti-angiogenic Peptide Anginex Greatly Enhances Galectin-1 Binding Affinity for Glycoproteins
- (2011) Emma Salomonsson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metabolic Inhibition of Galectin-1-Binding Carbohydrates Accentuates Antitumor Immunity
- (2011) Filiberto Cedeno-Laurent et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Melanoma-associated genes, MXI1, FN1, and NME1, are hypoxia responsive in murine and human melanoma cells
- (2011) Magdalena Olbryt et al. MELANOMA RESEARCH
- Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
- (2011) Andrea Facciabene et al. NATURE
- Significance of galectins-1, -3, -4 and -7 in the progression of squamous cell carcinoma of the tongue
- (2011) Pollianna M. Alves et al. PATHOLOGY RESEARCH AND PRACTICE
- Normalization of the Vasculature for Treatment of Cancer and Other Diseases
- (2011) Shom Goel et al. PHYSIOLOGICAL REVIEWS
- Galectin-1-Binding Glycoforms of Haptoglobin with Altered Intracellular Trafficking, and Increase in Metastatic Breast Cancer Patients
- (2011) Michael C. Carlsson et al. PLoS One
- Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model
- (2010) Kimberley A. Stannard et al. CANCER LETTERS
- Imaging Cycling Tumor Hypoxia
- (2010) S. Matsumoto et al. CANCER RESEARCH
- Tumor Cells Secrete Galectin-1 to Enhance Endothelial Cell Activity
- (2010) V. L. Thijssen et al. CANCER RESEARCH
- Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer
- (2010) R. K. Shrimali et al. CANCER RESEARCH
- Hypoxia inducible factor-1 mediates expression of galectin-1: the potential role in migration/invasion of colorectal cancer cells
- (2010) Xu-Yun Zhao et al. CARCINOGENESIS
- Identification and consequences of galectin-3 expression in pituitary tumors
- (2010) A. Righi et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs
- (2010) K. N. Sugahara et al. SCIENCE
- Role of the JNK/c-Jun/AP-1 signaling pathway in galectin-1-induced T-cell death
- (2010) B Brandt et al. Cell Death & Disease
- Calpain activation through galectin-3 inhibition sensitizes prostate cancer cells to cisplatin treatment
- (2010) Y Wang et al. Cell Death & Disease
- Inhibiting Tumor Growth by Targeting Tumor Vasculature with Galectin-1 Antagonist Anginex Conjugated to the Cytotoxic Acylfulvene, 6-Hydroxylpropylacylfulvene
- (2009) Ruud P. M. Dings et al. BIOCONJUGATE CHEMISTRY
- Silencing of galectin-3 changes the gene expression and augments the sensitivity of gastric cancer cells to chemotherapeutic agents
- (2009) Teak-Chin Cheong et al. CANCER SCIENCE
- Galectin-1 induced activation of the mitochondrial apoptotic pathway: evidence for a connection between death-receptor and mitochondrial pathways in human Jurkat T lymphocytes
- (2009) Falko Lange et al. HISTOCHEMISTRY AND CELL BIOLOGY
- T-cell growth, cell surface organization, and the galectin-glycoprotein lattice
- (2009) Ani Grigorian et al. IMMUNOLOGICAL REVIEWS
- The Cooperative Induction of Hypoxia-Inducible Factor-1 and STAT3 during Hypoxia Induced an Impairment of Tumor Susceptibility to CTL-Mediated Cell Lysis
- (2009) M. Z. Noman et al. JOURNAL OF IMMUNOLOGY
- Characterisation of Oxidized Recombinant Human Galectin-1
- (2009) Stacy A. Scott et al. PROTEIN AND PEPTIDE LETTERS
- The Galectin Profile of the Endothelium
- (2008) Victor L. Thijssen et al. AMERICAN JOURNAL OF PATHOLOGY
- Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells
- (2008) J. Klibi et al. BLOOD
- Tumor-Associated Galectin-3 Modulates the Function of Tumor-Reactive T Cells
- (2008) W. Peng et al. CANCER RESEARCH
- Galectins: structure, function and therapeutic potential
- (2008) Ri-Yao Yang et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- N-Glycans in cancer progression
- (2008) K. S Lau et al. GLYCOBIOLOGY
- Novel insights into the inhibitory effects of Galectin-1 on neutrophil recruitment under flow
- (2008) D. Cooper et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Vascular normalization in Rgs5-deficient tumours promotes immune destruction
- (2008) Juliana Hamzah et al. NATURE
- Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells
- (2008) S H Hsieh et al. ONCOGENE
- Hypoxia and Aggressive Tumor Phenotype: Implications for Therapy and Prognosis
- (2008) P. Vaupel ONCOLOGIST
- Emergence of hormonal and redox regulation of galectin-1 in placental mammals: Implication in maternal-fetal immune tolerance
- (2008) N. G. Than et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Serum Galectin-1 and Galectin-3 Levels in Benign and Malignant Nodular Thyroid Disease
- (2008) Sven Saussez et al. THYROID
- Evidence of galectin-1 involvement in glioma chemoresistance☆
- (2008) Marie Le Mercier et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Inhibitory effect of modified citrus pectin on liver metastases in a mouse colon cancer model
- (2008) Hai-Ying Liu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The immunoregulatory glycan-binding protein galectin-1 triggers human platelet activation
- (2007) Natalia Pacienza et al. FASEB JOURNAL
- The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy
- (2007) Sven Saussez et al. ORAL ONCOLOGY
- Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in early-stage oral squamous cell carcinoma
- (2007) Wei-Fan Chiang et al. ORAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now